ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43865
-0.01%
Bitcoin
83,917.79
-0.05%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) News

RZLT

Rezolute (RZLT)

Rezolute Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DateTimeSourceHeadlineSymbolCompany
02/20/20256:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/19/20258:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/19/20258:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/19/20257:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/19/20257:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/12/20253:28PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
02/12/20253:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
02/12/20253:05PMGlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
02/04/20254:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
02/04/20257:00AMGlobeNewswire Inc.Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
01/31/20257:00AMGlobeNewswire Inc.Rezolute to Participate in the Guggenheim SMID Cap Biotech ConferenceNASDAQ:RZLTRezolute Inc
01/14/20253:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
01/07/20257:00AMGlobeNewswire Inc.Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
12/30/20243:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RZLTRezolute Inc
12/10/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
12/05/20247:00AMGlobeNewswire Inc.Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RZLTRezolute Inc
12/03/20247:00AMGlobeNewswire Inc.FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor HyperinsulinismNASDAQ:RZLTRezolute Inc
11/14/20245:59PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RZLTRezolute Inc
11/12/20248:35AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RZLTRezolute Inc
11/07/20243:47PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
11/07/20243:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
11/07/20243:05PMGlobeNewswire Inc.Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
11/05/20247:00AMGlobeNewswire Inc.Rezolute to Participate in Upcoming Investor ConferencesNASDAQ:RZLTRezolute Inc
10/21/20243:43PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RZLTRezolute Inc
10/21/20243:41PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RZLTRezolute Inc
10/10/20243:40PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RZLTRezolute Inc
09/24/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
09/19/20243:23PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RZLTRezolute Inc
09/19/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
09/19/20243:05PMGlobeNewswire Inc.Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Your Recent History

AMEX
AGG
US Aggregate
NYSE
NIC
Nicolet Bankshares
TG
01T
Tokyu
NYSE
SLF
Sun Life Financial
NYSE
APH
Amphenol
LSE
XDNU
Xjpnk400 $
NYSE
AMG
Affiliated Managers
BIT
UBIOTC
UniCredit Bank
NYSE
BVN
Compania De Minas Buenav...
BIT
S29358
Societe Generale Effekten
NYSE
PPL
PPL
NYSE
PGR
Progressive
NYSE
MOH
Molina Healthcare
NYSE
RMD
ResMed
NYSE
PLD
Prologis
BIT
S28653
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads